معرفی
Vikas Gupta, MD, PhD, is an Assistant Professor in the Department of Medicine (Digestive Diseases) and Pathology at Yale School of Medicine. He serves as the Clinical Director of the Yale Fatty Liver Disease Program. His clinical expertise focuses on gastroenterology and hepatology, with a specialization in liver diseases, metabolic dysfunction-associated steatotic liver disease (MASLD), and medical weight management. Dr. Gupta’s research interests span multiple myeloma, biomarkers in hematologic malignancies, and the intersection of liver disease with systemic physiology.
Education: MD and PhD from Duke University School of Medicine (2014), BS in Biology from Pennsylvania State University (2007). Residency at Massachusetts General Hospital (2015–2016), Fellowship at Weill Cornell Medical College (2020).
Research Interests: His work explores cell biology of liver diseases, genomic determinants in multiple myeloma, and translational applications of biomarkers. Key areas include BCL2 inhibition for hematologic cancers, immune-aging in myeloma patients, and weight management strategies for liver health.
Publications: Over 20 peer-reviewed articles in journals like Blood, British Journal of Haematology, and Digestive Diseases and Sciences. Recent studies focus on therapeutic resistance in multiple myeloma and clinical outcomes in MASLD patients.
Awards: Recognized with the Junior Faculty Samuel Kushlan Award (2023), Early Career Investigator in Basic Science (2020), and Kellen Fellowship (2019).
Labs & Teams: Collaborates with the Gupta Lab and interdisciplinary teams at Yale, including the Molecular Medicine Program and the Fatty Liver Disease Program.
